Literature DB >> 16139658

Public-health impact of accelerated measles control in the WHO African Region 2000-03.

M Otten1, R Kezaala, A Fall, B Masresha, R Martin, L Cairns, R Eggers, R Biellik, M Grabowsky, P Strebel, J-M Okwo-Bele, D Nshimirimana.   

Abstract

BACKGROUND: In 2000, the WHO African Region adopted a plan to accelerate efforts to lower measles mortality with the goal of decreasing the number of measles deaths to near zero. By June, 2003, 19 African countries had completed measles supplemental immunisation activities (SIA) in children aged 9 months to 14 years as part of a comprehensive measles-control strategy. We assessed the public-health impact of these control measures by use of available surveillance data.
METHODS: We calculated percentage decline in reported measles cases during 1-2 years after SIA, compared with 6 years before SIA. On the basis of data from 13 of the 19 countries, we assumed that the percentage decline in measles deaths equalled that in measles cases. We also examined data on routine and SIA measles vaccine coverage, measles case-based surveillance, and suspected measles outbreaks.
FINDINGS: Between 2000 and June, 2003, 82.1 million children were targeted for vaccination during initial SIA in 12 countries and follow-up SIA in seven countries. The average decline in the number of reported measles cases was 91%. In 17 of the 19 countries, measles case-based surveillance confirmed that transmission of measles virus, and therefore measles deaths, had been reduced to low or very low rates. The total estimated number of deaths averted in the year 2003 was 90,043. Between 2000 and 2003 in the African Region as a whole, we estimated that the percentage decline in annual measles deaths was around 20% (90,043 of 454,000).
INTERPRETATION: The burden of measles in sub-Saharan Africa can be reduced to very low levels by means of appropriate strategies, resources, and personnel.

Entities:  

Mesh:

Year:  2005        PMID: 16139658     DOI: 10.1016/S0140-6736(05)67216-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  35 in total

1.  Associations between demographic variables and multiple measles-specific innate and cell-mediated immune responses after measles vaccination.

Authors:  Benjamin J Umlauf; Iana H Haralambieva; Inna G Ovsyannikova; Richard B Kennedy; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Viral Immunol       Date:  2012-01-12       Impact factor: 2.257

2.  Measles in a tertiary institution in bida, niger state, Nigeria: prevalence, immunization status and mortality pattern.

Authors:  Muhammed Adeboye; Omotayo Adesiyun; Abdulrasheed Adegboye; Edith Eze; Usman Abubakar; Grace Ahmed; Abdullahi Usman; Solomon Amos; Bf Rotimi
Journal:  Oman Med J       Date:  2011-03

Review 3.  The human story.

Authors:  R Bruce Aylward; Maureen Birmingham
Journal:  BMJ       Date:  2005-11-26

Review 4.  Biological feasibility of measles eradication.

Authors:  William J Moss; Peter Strebel
Journal:  J Infect Dis       Date:  2011-07       Impact factor: 5.226

5.  Enhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013.

Authors: 
Journal:  Public Health Rep       Date:  2014       Impact factor: 2.792

6.  Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.

Authors:  Ianko D Iankov; Manoj Pandey; Mary Harvey; Guy E Griesmann; Mark J Federspiel; Stephen J Russell
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

7.  Outbreak of measles among persons with secondary vaccine failure, China, 2018.

Authors:  Zhujiazi Zhang; Meng Chen; Rui Ma; Jingbin Pan; Luodan Suo; Li Lu
Journal:  Hum Vaccin Immunother       Date:  2019-09-05       Impact factor: 3.452

8.  Validating child vaccination status in a demographic surveillance system using data from a clinical cohort study: evidence from rural South Africa.

Authors:  James Ndirangu; Ruth Bland; Till Bärnighausen; Marie-Louise Newell
Journal:  BMC Public Health       Date:  2011-05-23       Impact factor: 3.295

Review 9.  Immunization in patients with HIV infection: are practical recommendations possible?

Authors:  Brian Eley
Journal:  Drugs       Date:  2008       Impact factor: 9.546

10.  Assessment of measles immunity among infants in Maputo City, Mozambique.

Authors:  Jagrati V Jani; Carol Holm-Hansen; Tufária Mussá; Arlinda Zango; Ivan Manhiça; Gunnar Bjune; Ilesh V Jani
Journal:  BMC Public Health       Date:  2008-11-12       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.